You are here: Industry Insights > HIV

News List

Among Persons With HIV, More Finish Short-Course TB Prophylaxis drugs
August 24, 2021
Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy, according to a study published online Aug. 24 .
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice expresspharma
August 09, 2021
Arun Kedia, Managing Director, VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across various medical therapies ranging from HIV to cancer to COVID-19 treatment.
PrEP HIV Prevention Pills to Be Free for Insured Americans drugs
July 22, 2021
Nearly all health insurers must cover the entire cost of HIV prevention treatments, the U.S. government says. That includes the two approved pre-exposure prophylaxis(PrEP) drugs Truvada and Descovy, all clinic visits, and lab tests, NBC News reported.
Frontier Biotechnologies' First Long-acting Injectable (Aikening(R)), in a Two Drug Regimen for HIV, Proves Safe and Efficacious for Patients prnasia
July 20, 2021
In conjunction with the IAS Conference on HIV Science, Frontier Biotechnologies announced positive top-line results for its phase 3 TALENT study, which demonstrated that an ABT-based two-drug treatment arm was non-inferior to a lopinavir (LPV)-based ...
People With HIV Have Much Higher Risk for Suicide drugs
July 07, 2021
Since the advent of AIDS, major advancements in treating HIV infection has turned what used to be a death sentence into a manageable chronic condition.
Zydus Cadila receives final approval from USFDA for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets expresspharma
July 05, 2021
Zydus Cadila has received final approval from the USFDA to market Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 100 mg/150 mg, 133 mg/200 mg and 167 mg/250 mg, a company statement said.
Collaboration to develop ultra-long acting medicines for HIV europeanpharmaceuticalreview
June 23, 2021
ViiV Healthcare is licencing Halozyme’s Enhanze® drug delivery technology to help develop ultra-long acting versions of its long-acting HIV pipeline products.
Monoclonal antibody prevents HIV infection in monkeys, study finds worldpharmanews
June 10, 2021
An experimental, lab-made antibody can completely prevent nonhuman primates from being infected with the monkey form of HIV, new research published in Nature Communications shows.
CGTN: Peng Liyuan calls for global efforts in AIDS and TB prevention and treatment prnasia
June 08, 2021
Peng Liyuan, wife of Chinese President Xi Jinping, called on people from all walks of life in all countries to join hands and take action to strengthen the prevention and treatment of AIDS and tuberculosis (TB), in order to benefit all mankind and ...
Lupin gets USFDA nod to market generic HIV drug expresspharma
June 08, 2021
The company has received approval from the United States Food and Drug Administration (USFDA) to market its emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg, Lupin said in a regulatory filing.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 24 25 Next page